CORRADO, ADDOLORATA
 Distribuzione geografica
Continente #
EU - Europa 4.046
NA - Nord America 3.879
AS - Asia 1.222
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 6
SA - Sud America 6
Totale 9.178
Nazione #
US - Stati Uniti d'America 3.872
IE - Irlanda 1.580
CN - Cina 1.034
UA - Ucraina 990
SE - Svezia 737
IT - Italia 192
FR - Francia 170
FI - Finlandia 140
TR - Turchia 99
GB - Regno Unito 79
DE - Germania 71
IN - India 58
BE - Belgio 21
PL - Polonia 13
AT - Austria 10
NL - Olanda 10
EU - Europa 8
RU - Federazione Russa 8
DK - Danimarca 7
HK - Hong Kong 7
SG - Singapore 6
CA - Canada 5
JP - Giappone 5
NZ - Nuova Zelanda 5
EG - Egitto 4
CL - Cile 3
ID - Indonesia 3
RO - Romania 3
CH - Svizzera 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
ES - Italia 2
GR - Grecia 2
HR - Croazia 2
KR - Corea 2
MD - Moldavia 2
MX - Messico 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
AU - Australia 1
BD - Bangladesh 1
BR - Brasile 1
DZ - Algeria 1
IQ - Iraq 1
IR - Iran 1
MA - Marocco 1
MN - Mongolia 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
TW - Taiwan 1
VN - Vietnam 1
Totale 9.178
Città #
Dublin 1.578
Chandler 717
Jacksonville 657
Nyköping 502
Dearborn 455
Nanjing 299
Beijing 186
Princeton 163
Wilmington 157
Nanchang 94
San Mateo 90
Ashburn 86
Ann Arbor 77
Shenyang 73
New York 65
Helsinki 63
Des Moines 51
Tianjin 49
Hebei 46
Los Angeles 42
Kunming 39
Foggia 37
Woodbridge 36
Changsha 33
Jiaxing 33
Boardman 30
Zhengzhou 24
Hangzhou 23
Jinan 21
London 19
Guangzhou 17
Brussels 16
Seattle 16
Norwalk 15
Lanzhou 14
Ningbo 13
Hanover 11
Hefei 11
Shanghai 11
Taizhou 11
Chicago 10
Milan 10
Noci 10
San Severo 10
Washington 10
Bari 9
Pune 9
Stevenage 9
Changchun 8
Klagenfurt 8
Kraków 8
Orange 7
Paris 7
West Jordan 7
Auburn Hills 6
Cutrofiano 6
Greifswald 6
Bologna 5
Chieti 5
Haikou 5
Hilden 5
Naples 5
Auckland 4
Fuzhou 4
Redwood City 4
Saint Petersburg 4
Brindisi 3
Polverigi 3
Rockville 3
Rome 3
Schenectady 3
Serra 3
Singapore 3
Abidjan 2
Altamura 2
Athens 2
Baotou 2
Buffalo 2
Cambridge 2
Catanzaro 2
Chisinau 2
Clearwater 2
Council Bluffs 2
Fairfield 2
Ferrara 2
Frankfurt am Main 2
Gallipoli 2
Harrah 2
Houston 2
Iasi 2
Johannesburg 2
Leawood 2
Lucera 2
Martinsicuro 2
Milton Keynes 2
Novokuznetsk 2
Nuremberg 2
Ottawa 2
Pickering 2
Portici 2
Totale 6.136
Nome #
Nailfold capillaroscopic findings in systemic sclerosis related lung fibrosis and in idiopathic lung fibrosis 112
Extra-skeletal effects of bisphosphonates. 106
Dose-dependent metabolic effect of zoledronate on primary human osteoblastic cell cultures. 101
Two cases of distal extremity swelling with pitting oedema in psoriatic arthritis: the different pathological mechanisms. 99
SUBSTANCE P AND VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION BY PERIPHERAL BLOOD MONONUCLEAR CELLS DERIVING FROM PATIENTS WITH SYSTEMIC SCLEROSIS 98
Synovial fluid fibroblasts and lymphocytes support the osteoclastogenesis in human psoriatic arthritis 95
Corticosteroids, a review. 91
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease. 91
COUNSELLING ON FAMILY PLANNING AND CONTRACEPTION, AND PREGNANCY OUTCOME IN WOMEN WITH RHEUMATIC DISEASES: A NATIONAL SURVEY OF 398 PATIENT-REPORTED QUESTIONNAIRES FROM 24 RHEUMATOLOGY CENTERS 86
THE ROLE OF TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN THE STUDY OF LIVER FIBROSIS IN SSc 85
Extracellular Matrix modulates angiogenesis in physiological and pathological conditions 84
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 84
Effect of endothelin inhibition on lung fibroblasts on patients with systemic sclerosis 82
Comments on Addolorata Corrado et al. review “Extra-skeletal effects of bisphosphonates” 82
Combined effect of Neridronate and specific antibiotic therapy in a case of tuberculous spondylodiscitis 81
Extracellular matrix interactions with osteoblasts in osteoarthritis. A preliminary report 81
Bisphosphonates: effects on osteoblast. 80
Pubic symphysis sclerosis in psoriatic arthritis. Case report. 78
IgA nephropathy in systemic lupus erythematosus. 77
Juvenile idiopathic arthritis: an update on clinical and therapeutic approaches 77
Mitochondrial disease mimicking polymyositis: a case report 76
TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis. 76
Intestinal histological and ultrastructural inflammatory changes in spondyloarthropathy and rheumatoid arthritis. 75
Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis 75
Role of altered osteoblastic expression of Dkk-1 in the pathogenesis of osteoarthritis and osteoporosis 74
Melkersson-Rosenthal syndrome in a patient with psoriatic arthritis receiving etanercept. 73
Anti-TNF-α and risk of infections: the experience in one center. 73
Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study 73
Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D Serum Levels in Systemic Sclerosis 72
Osteoporosis and rheumatic diseases 71
Abnormalities of insulin-like growth factor-I signaling and impaired cell proliferation in osteoblasts from subjects with osteoporosis 71
Bone effects of biologic drugs in rheumatoid arthritis. 70
Adult Scheuermann's disease as cause of mechanic dorsalgia 69
RANKL/OPG Ratio and DKK-1 Expression in Primary Osteoblastic Cultures from Osteoarthritic and Osteoporotic Subjects 69
Impact of Systematic Isolation of Superior Vena Cava in Addition to Pulmonary Vein Antrum Isolation on the Outcome of Paroxysmal, Persistent, and Permanent Atrial Fibrillation Ablation: Results from a Randomized Study 68
Osteocytes: central conductors of bone biology in normal and pathological conditions 68
Metabolic effects of zoledronate on primary human osteoblastic cell cultures 68
Bilateral sequential central retinal vein occlusion associated with primary antiphospholipid syndrome 68
AN EXEMPLAR BEHCET CASE, IN ALL ITS MULTISYSTEMIC FEATURES 68
Pathogenesis, clinical findings and management of acute and chronic gout. 68
Successful treatment of avascular bone necrosis of the knee with neridronate: a case report 67
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: A EUSTAR analysis 67
Bisphosphonates and osteoarthritis 67
Membranous nephropathy in rheumatoid arthritis: a case report. 66
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study 66
Angiogenesis Dysregulation in Psoriatic Arthritis: Molecular Mechanisms 66
1,25OH-Vitamin D3 and IL-17 Inhibition Modulate Pro-Fibrotic Cytokines Production in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis 65
Psoriatic arthritis and Klinefelter syndrome: case report. 65
Neridronate and osteoporotic and ostearthitic human osteoblasts 65
Anabolic therapy of induced osteoporosisin beta-thalassaemia major: case report and literature review 65
Integrine expression on human osteoblasts in osteoarthritis 65
T cells support osteoclastogenesis in an in vitro model derived from human psoriatic arthritis 65
In vitro and in vivo angiogenic activity of osteoarthritic and osteoporotic osteoblasts is modulated by VEGF and vitamin D3 treatment 65
Anti-TNF-α effects on anemia in rheumatoid and psoriatic arthritis 65
Pathogenesis of ligaments ossification in spondyloarthritis: insights and doubts 65
SERUM 25(OH) VITAMIN D LEVELS, BODY MASS COMPOSITION AND EXTENT OF SKIN SCLEROSIS IN SYSTEMIC SCLEROSIS PATIENTS 65
Cervical myelopathy caused by periodontoid synovial pannus in a patient with psoriatic arthritis: a case report. 64
Glucocorticoid induced risk of fractures. 64
Expression of vascular endothelial growth factor in normal, osteoarthritic and osteoporotic osteoblasts. 64
Immunomodulatory effects of vitamin D in peripheral blood monocyte-derived macrophages from patients with rheumatoid arthritis 64
Anomalies de la capillaroscopie périunguéale au cours de la fibrose pulmonaire associée à la sclérodermie systémique et au cours de la fibrose pulmonaire idiopathique 64
Phenotyping of chondrocytes from human osteoarthritic cartilage: chondrocyte expression of beta integrins and correlation with anatomic injury 63
Effects of Infliximab on human osteoblastic cells from rheumatoid arthrtis subjects 63
Osteocalcin: Skeletal and extra-skeletal effects 63
Multiprofessional and intrahospital experience for diagnosis and treatment of pulmonary arterial hypertension 63
Angiogenesis Dysregulation in the Pathogenesis of Systemic Sclerosis 63
Anti-angiogenic effects of biotechnological therapies in rheumatic diseases 63
Normal and osteoporotic human osteoblast behaviour after 1,25-dihydroxy-vitamin D(3) stimulation 62
Fibromialgic syndrome: new perspectives in rehabilitation and management. A review 62
Combined effects of infliximab and methotrexate on rheumatoid arthritis osteoblastic cell metabolism 62
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association. 62
Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension 61
Dupuytren's disease. State of the art and therapeutic perspectives 60
Effects of Infliximab on human osteoblastic cells from rheumatoid arthritis subjects 60
The bisphosponates: chemical characteristics, skeletal biological effects and extra-skeletal effects 59
Multiprofessional and intrahospital experience for diagnosis and treatment of pulmonary arterial hypertension 59
Osteoblast as a target of anti-osteoporotic treatment 59
Morphologic study of the microcirculation in connective tissue diseases 58
Neridronate and human osteoblasts in normal, osteoporotic and osteoarthritic subjects 58
Osteoblast physiology in normal and pathological conditions 58
EFFECTS OF DIFFERENT ANTI TNF ALPHA TREATMENTS ON LIPID AND CARBOHYDRATE METABOLISM IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS 58
Glucocorticoid induced risk of fractures 58
1,25OH-Vitamin D3 and IL-17 Inhibition Modulate Pro-Fibrotic Cytokines Production in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis 57
Osteocalcin synthesis by human osteoblasts from normal and osteoarthritic bone after vitamin D3 stimulation 57
Iloprost treatment in large-vessel vasculitis during systemic lupus erythematosus 57
VITAMIN D DOWN-REGULATES PRO-INFLAMMATORY CYTOKINE RESPONSE IN RHEUMATOID ARTHRITIS PERIPHERAL MACROPHAGES 57
La coxalgia 56
Systemic effects of Wnt signaling 56
Digital ulcers predict a worse disease course in patients with systemic sclerosis 56
COUNSELING ON FAMILY PLANNING AND CONTRACEPTION IN PATIENTS WITH RHEUMATIC DISEASES: ANALYSIS OF 324 PATIENT-REPORTED QUESTIONNAIRES FROM A MULTICENTER ITALIAN STUDY 56
Janus kinase inhibitors role in bone remodeling 56
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. 55
TNF-related apoptosis-inducing ligand (TRAIL) in rheumatoid arthritis: what's new? 55
ANTI-CARBAMYLATED PROTEIN ANTIBODIES IN PATIENTS WITH SYSTEMIC SCLEROSIS: AN INTRIGUING ASSOCIATION WITH SKIN INVOLVEMENT 55
Anti-angiogenic effects of anti–tumor necrosis factor α agents in the treatment of behçet disease 55
Why TNF-α inhibition is not sufficient to avoid juxta-articular erosions in chronic arthritis? 54
INHIBITORY EFFECT OF 1,25OH VITAMIN D ON IL-17 RELATED PRO-FIBROTIC CYTOKINES EXPRESSION IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH SYSTEMIC SCLEROSIS 54
Reply to the letter by Baldeep Singh on the review entitled "Extra skeletal effects of bisphosphonates" 53
SYSTEMIC SCLEROSIS AND RECURRENT PREGNANCY LOSS: POSSIBLE ROLE OF AUTOANTIBODY PROFILE AND MICROVASCULAR DAMAGE 53
THU0145 Changes in bone metabolism and trabecular bone score in patients with early rheumatoid arthritis 52
Totale 6.832
Categoria #
all - tutte 51.819
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.819


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019163 0 0 0 0 0 0 0 0 0 0 39 124
2019/20202.115 410 239 70 26 234 309 308 41 224 23 194 37
2020/20211.269 181 17 164 10 155 56 175 162 173 160 3 13
2021/2022840 99 13 9 9 65 18 28 72 134 125 34 234
2022/20233.695 325 162 171 154 191 329 20 310 1.802 30 96 105
2023/2024496 108 40 45 30 44 142 15 28 1 38 5 0
Totale 9.768